Phase 2 Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing to take part voluntarily, have been fully informed about the study, and have signed a consent form
- You are willing and able to follow all study procedures and attend all required visits
- You are a woman between 18 and 75 years old
- You are generally healthy and able to carry out daily activities with little or no limitation (confirm with trial site)
- Your cervical cancer has been confirmed by a tissue sample (biopsy) as one of three specific types: squamous cell, adenocarcinoma, or adenosquamous carcinoma
- Your cancer is at a certain stage — either an earlier stage with cancer found in nearby lymph nodes, or a more advanced stage that has not spread to distant parts of the body (confirm with trial site)
- Your blood counts, liver, and kidney are functioning well enough to meet the study's requirements (confirm with trial site)
- You have not received any previous cancer treatment
- You are expected to live longer than 6 months
- You have had a negative pregnancy test within 14 days before starting treatment, agree to use effective contraception during the study and for 6 months after, and agree not to breastfeed during the study
Who may not be able to join:
- Your cervical cancer has been confirmed as a rare type called small cell cervical cancer
- Your cervical cancer has come back after previous treatment, or has spread to distant parts of the body
- You have received any prior cancer treatment
- You have had another active cancer in the past 5 years (except certain minor skin cancers or very early-stage cancers that were fully treated)
- You have an active or known autoimmune disease (a condition where your immune system attacks your own body)
- You currently have an active infection
- You have needed to take steroids or other medicines that suppress the immune system within the last 14 days before joining the study
- You have had a blood clot in a vein or artery within the last 6 months
- You have significant heart problems that are not well controlled
- You have a known allergy to the study drug or any of its ingredients, or have had a severe allergic reaction to a similar type of medication before
- You are currently pregnant or breastfeeding
- You have a neurological or psychiatric condition that affects your thinking or memory
- Your doctor believes there is any other reason that participating in this study would not be safe or suitable for you
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Maobin Meng, Tianjin Medical University Cancer Institute and Hospital
Phone: +86 15202231270
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
PFS; OS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.